Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share (OMIC)

CUSIP: 82933R308

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 5 signals
Share change
+409
SEC-reported price per share
$15.67
Number of holders
1
Value change
+$6,409
Number of buys
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
1,000

Security key

82933R308

Report period

Q3 2025

Institutions

1

Top holders

0

Ownership snapshot

Top reported holders of OMIC - Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
James E. Flynn
Disclosed value leader
James E. Flynn
Comparable rows
2/10
Latest evidence
21 Feb 2025
3/4/5 13D/G Lead comparable stake: 100% 8 rows are not safely comparable across share classes. 13D/G row: James E. Flynn Showing 1-6 of 10 holder rows.

Quick read

James E. Flynn leads the comparable SEC ownership view at 100%.

2 of 10 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens James E. Flynn's linked filing trail.
Comparable ownership Top 2
James E. Flynn 100%
Domain Partners IX, L.P. 5%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 10 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
James E. Flynn
3/4/5 13D/G
*Possible Member of 10% Group, 10%+ Owner · Deerfield Mgmt IV, L.P.
100%
from 13D/G
$3,891,028
9,142,019 shares
mixed-class rows
01 Jun 2021
Domain Partners IX, L.P.
13D/G
5%
$38,888
125,446 shares
$0 31 Dec 2024
Alexandria Venture Investments, LLC
3/4/5
10%+ Owner
class O/S missing
$1,120,310
2,645,985 shares
01 Jun 2021
Andrew Spaventa
3/4/5
Chief Executive Officer, Director
class O/S missing
$454,944
22,873 shares
21 Feb 2025
Jorge Velarde
3/4/5
Senior Vice President
class O/S missing
$143,956
340,000 shares
26 May 2021
Sam Ropp
3/4/5
Chief Commercial Officer
mixed-class rows
$138,368
167,000 shares
mixed-class rows
15 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Archived quarter

Historical 13F summary for Q3 2025

This older quarter remains available as an indexed ownership summary. Detailed holder rows are no longer kept in the hot table for this period.

There are no holders of OMIC - Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .